Tobacco Dependence
149
12
13
114
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
48 trials with published results (32%)
Research Maturity
114 completed trials (77% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
4.7%
7 terminated out of 149 trials
94.2%
+7.7% vs benchmark
19%
29 trials in Phase 3/4
42%
48 of 114 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 114 completed trials
Clinical Trials (149)
Varenicline for Smoking Reduction in Veterans Not Ready To Quit
Effect of Nicotine Gingival Fibroblast Intoxication on the Response of Periodontal Treatment
Assessment of Biomarkers in Children to Help Parents Quit Tobacco
Cannabidiol for Reducing Cigarette Use
Cytisine vs Nicotine Replacement Therapy
Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation
Addictive Potential of LCCs in Dual Users
Tobacco Cessation Care for Cancer Patients by Automated Interactive Outreach
C-Raven, a Virtual Tobacco Cessation Intervention in the Community
C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics
Harm Reduction for Smokers With Mental Illness
DBT for Smoking Cessation in High Risk Veterans
Oral Cannabidiol for Tobacco Cessation
Positive Psychology for Smoking Cessation
Effect of Yoga on Reducing Craving in Tobacco Dependent Individuals
Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness
Use of Nicotine Pouches Among Daily Smokers
Identifying Effective Treatment for Veterans Unwilling to Quit Smoking
Testing the Effect of ENDS Flavors on Neurotransmission
Low Nicotine Cigarettes Plus Electronic Cigarettes